ClinicalTrials.gg
Drug

Zeprumetostat clinical trials

Also written SHR2554.

studies test it
39
open now
28
in phase 3
1
first study started
2018

How each study uses zeprumetostat is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the zeprumetostat studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Zeprumetostat
7
SHR2554 Tablets
3
Zeprumetostat Tablets
2

Development codes

SHR2554
13
TLN-254
1

Studies by the year they started

39 studies that test it; most in 2026 (14)

Studies that test zeprumetostat, by start year
YearStudies
20182
20191
20204
20222
20235
20246
20255
202614

Who runs them

Industry 16 · Other 23

Jiangsu HengRui Medicine Co., Ltd. (15) · Fudan University (4) · Institute of Hematology & Blood Diseases Hospital, China (4) · Ruijin Hospital (3) · Sun Yat-sen University (2) · Chinese PLA General Hospital (2) · Treeline Biosciences, Inc. (1) · Peking University First Hospital (1)

Often tested with

Tested in the same studies.

SHR-1701 (6) · Tucidinostat (3) · Apatinib (2) · Azacitidine (2) · Golidocitinib (2) · Linperlisib (2) · Camrelizumab (2) · Selinexor (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 5

Studies that test zeprumetostat.

Studies

Open first, then newest update. How each study uses zeprumetostat is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 39

See all 39 studies that test zeprumetostat →

Given beside what is tested · 2 — zeprumetostat is usual care or a partner of the new treatment
As the comparator · 1 — what is tested is compared with zeprumetostat

What changed recently

From the registry's own updates since Oct 18, 2026.

Codes

What other systems call zeprumetostat · ClinicalTrials.gg INT018479

  • UNII (FDA) XLJ9D8HE8YZEPRUMETOSTATOne source FDA
  • NCI Thesaurus C158742ZeprumetostatOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.